INDIVIDUAL PEPTIDE PROFILE
CJC-1295
A synthetic growth hormone-releasing hormone analogue developed to stimulate endogenous growth hormone and IGF-1 signaling.
WHAT IS CJC-1295?
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, commonly abbreviated GHRH.
It was designed to stimulate the pituitary gland to increase the body’s own secretion of growth hormone, which can subsequently increase insulin-like growth factor-1, or IGF-1.
CJC-1295 is frequently discussed in anti-aging, body-composition and recovery communities, but those marketed uses extend considerably beyond the strength of available clinical evidence.
WHY RESEARCHERS ARE INTERESTED
Researchers have investigated whether longer-lasting GHRH analogues can produce sustained increases in endogenous growth hormone and IGF-1.
This makes CJC-1295 scientifically relevant to the study of:
- Growth hormone physiology
- IGF-1 signaling
- Endocrine regulation
- Body-composition hypotheses
- Age-related changes in the GH/IGF-1 axis
HOW IT WORKS
Rather than supplying growth hormone directly, CJC-1295 stimulates signaling at the pituitary gland through the growth hormone-releasing hormone pathway.
Early human research demonstrated that CJC-1295 can produce measurable increases in growth hormone and IGF-1.
Demonstrating a hormonal change is not the same as proving a meaningful health outcome.
WHAT THE RESEARCH SHOWS
Small human pharmacology studies established that CJC-1295 can increase circulating GH and IGF-1.
What has not been established through large high-quality clinical trials is that CJC-1295 produces the broad anti-aging, muscle-building, fat-loss, recovery or longevity effects frequently promoted online.
Terminology matters
CJC-1295 WITH DAC VS WITHOUT DAC
CJC-1295 terminology can be confusing because products described as CJC-1295 with DAC and products marketed as CJC-1295 without DAC may have substantially different pharmacologic characteristics.
Research findings involving one form should not automatically be applied to another.
Research Reality Check
What we know
Human pharmacology research demonstrates that certain forms of CJC-1295 can increase GH and IGF-1.
What remains uncertain
The clinical significance of those increases for healthy aging, muscle development, fat reduction, recovery, long-term health and longevity.
SAFETY & REGULATORY STATUS
CJC-1295 is not FDA approved for anti-aging, body composition or general wellness.
FDA has raised concerns regarding compounded CJC-1295, including potential immunogenicity and peptide-related impurities, and has identified serious adverse events including increased heart rate and systemic vasodilatory reactions.
Available clinical safety information remains limited.
Educational commentary, not personal testimonial
Vince’s Take
CJC-1295 demonstrates one of the most important principles in peptide education:
Showing that a compound raises a hormone does not automatically prove that raising that hormone creates the outcome being advertised.
That’s exactly where evidence-based education becomes important.
QUESTIONS PEOPLE OFTEN ASK
SOURCES & FURTHER READING
EDUCATIONAL NOTICE
The Balanced Body Lifestyle provides peptide and wellness information for educational purposes only. Content is intended to help readers better understand emerging research, established evidence and areas of scientific uncertainty. It is not medical advice, diagnosis, treatment guidance or a recommendation to use any medication, peptide or research compound. Decisions involving prescription medications or investigational compounds should be discussed with a qualified healthcare professional.
BALANCED BODY LIFESTYLE
A healthy life is built on balance.